Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)
China flag China · Delayed Price · Currency is CNY
9.19
+0.11 (1.21%)
At close: Feb 3, 2026

SHA:600789 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
786.36772.54798.46688.81576.85647.69
Trading Asset Securities
-1.221.191.261.211.09
Cash & Short-Term Investments
786.36773.76799.65690.07578.06648.78
Cash Growth
-13.54%-3.24%15.88%19.38%-10.90%-28.41%
Accounts Receivable
1,3981,4371,3461,232824.41858.35
Other Receivables
265.43354.7814.9718.4231.3638.87
Receivables
1,6631,7921,3611,251855.76897.22
Inventory
1,2671,4841,4061,4811,208869.07
Prepaid Expenses
-3.982.821.29--
Other Current Assets
97.9776.5478.3286.17109.4992.3
Total Current Assets
3,8144,1303,6483,5092,7512,507
Property, Plant & Equipment
3,8083,8333,8874,0473,9213,750
Long-Term Investments
82.888103.1389.8469.6789.32
Other Intangible Assets
778.34766.2724.04603.01570.13395.08
Long-Term Deferred Tax Assets
22.7224.0331.0225.9821.6618.82
Long-Term Deferred Charges
168.12128.4107.79148.58170.17187.17
Other Long-Term Assets
142.19128.52301.58304.76318.47325.55
Total Assets
8,8169,0988,8028,7287,8227,273
Accounts Payable
1,1051,5031,5031,6111,1641,154
Accrued Expenses
16.75144.57140.38145.08104.2799.47
Short-Term Debt
1,038871.771,1021,3441,2821,560
Current Portion of Long-Term Debt
723.38282.56464.63640.6673.0744.74
Current Portion of Leases
---1.570.88-
Current Income Taxes Payable
24.041.975.94.675.4610.45
Current Unearned Revenue
71.77167.61209.08216.6129.4995.32
Other Current Liabilities
211.2889.7692.2165.3118.36162.35
Total Current Liabilities
3,1913,0613,5174,1293,4783,126
Long-Term Debt
1,2421,6861,309867.18692.4550.95
Long-Term Leases
----0.6225.81
Long-Term Unearned Revenue
155.22165.72110.97100.4199.0483.64
Other Long-Term Liabilities
123.86123.86123.86123.86123.86126.66
Total Liabilities
4,7125,0365,0615,2204,3943,914
Common Stock
898.67898.67896.04886.88880.6880.23
Additional Paid-In Capital
1,6981,6981,6831,6301,6531,632
Retained Earnings
1,3831,3421,047849.26755.36702.64
Comprehensive Income & Other
-22.76-21.06-14.29-9.59-5.58-0.99
Total Common Equity
3,9573,9183,6123,3573,2833,214
Minority Interest
147.81143.39129.65150.31145.17145.29
Shareholders' Equity
4,1054,0623,7413,5073,4283,359
Total Liabilities & Equity
8,8169,0988,8028,7287,8227,273
Total Debt
3,0032,8402,8762,8542,6492,181
Net Cash (Debt)
-2,217-2,066-2,076-2,164-2,071-1,533
Net Cash Per Share
-2.49-2.30-2.36-2.35-2.32-1.68
Filing Date Shares Outstanding
898.67898.67896.04886.88880.6880.23
Total Common Shares Outstanding
898.67898.67896.04886.88880.6880.23
Working Capital
623.781,069130.46-620.23-727.25-619.14
Book Value Per Share
4.404.364.033.793.733.65
Tangible Book Value
3,1793,1522,8882,7542,7132,819
Tangible Book Value Per Share
3.543.513.223.113.083.20
Buildings
-2,2222,1001,9751,8021,634
Machinery
-3,8033,6293,5033,0542,859
Construction In Progress
-121.86100.97175.53359.25263.75
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.